In an attempt to localize the guanine nucleotide binding protein Gsa by immunocytochemistry, we synthetized peptides corresponding to several stretches of residues deduced from the published D N A sequence of Gsa and raised antibodies against them. Among the peptides, one corresponding to residues 367-381 elicited antibodies that immunoqtochemically detected, at the optical level, what appeared to be vimentin in several cells and tissues. Studies at the ultrastructural level confiied this observation and also showed weak staining of some areas of plasma membranes of glial and nerve cells. Analysis by Western blots of rat brain subcellular fractions indicated that: (a) the protein stained by the anti-peptide antibodies was associated with the cystoskele-
Introduction
Adenylyl cyclase, one of the major signal-transducing systems in eukaryotes, is a membrane-bound, multicomponent enzyme composed of a catalyst, converting ATP to CAMP, and of regulatory subunits (1) . The stimulatory subunits Gs and the inhibitory subunits Gi belong to the well-known large family of trimeric G-proteins (2) . The enzyme-specific activity is high in mammalian brain, as can be expected. The involvement of CAMP in several neuronal and glial events is well documented, but its intervention in the process of neurotransmission has not been established. The knowledge of the precise cellular and subcellular distribution of adenylyl cyclase in brain would help understanding of its physiological roles and potential implications in diseases of the central nervous system.
Adenylyl cyclase catalytic activity cannot be detected in fixed tissues, since fixatives desensitize the enzyme to its effectors or destroy its activity, depending on the concentration of fixatives (3, 4) . Therefore, probes recognizing the protein itself, or the mRNA, ' Supported (URA 1455) by grants from the Centre National de la Recherche Scientifique and the Association Frangaise Contre les Myopathies.
Correspondence and present address: Ariane Monneron, Department des PrctEines de la Transduction, LCB CNRS, 31 Chemin Joseph-Aiguier, 13402 Marseille Cedex 20, France. ton; and (b) it was not vimentin but a protein of higher molecular weight, 65 KD. We accordingly suggest that the Gsaderived peptide elicited two types of antibodies, one recognizing Gsa in fmed tissues, the other recognizing an epitope located in a vimentin-associated protein. This study emphasizes the caution that is needed when conclusions are drawn on the basis of immunocytochemical studies using antipeptide antibodies. (J Hisrochem Cytochem 41: 7O9-717, 1993) KEY WORDS: Anti-peptide antibody immunocytochemistry; Gsa localization in rat cerebellum and various cell types; Vimentin; Western blots.
should be used. The cloning and sequencing of one species of adenylyl cyclase catalyst, called Type I, has recently been achieved ( 5 ) . This has allowed its regional localization in brain by in situ hybridization (6) . Immunocytochemical studies of the catalyst, which would give clues to its localization and abundance not only at the level of tissues but also at the cellular and subcellular levels, have not yet been published, with the exception of the olfactory enzyme (7, 8) . However, the localization of adenylyl cyclase in brain can be approached by studying the distribution of G,a-subunits. The only function known at present of Gs in brain is the transmission of stimulatory signals to adenylyl cyclase catalysts, whereas in a few other tissues additional functions are known. Besides, scarce as they are, Gsa-subunits outnumber by far the catalytic subunits, which appear to be exceedingly minor components of the plasma membrane (9) .
Attempts to localize G-proteins by immunocytochemistry in tissues, at the regional or more rarely the cellular level, mostly concern TU (10) . the abundant Goa subunits (11) (12) (13) . and other G-proteins such as Gila (1415). Golfs (7, 8) and, finally, Gsa (16).
Given the large number of Ga species that coexist within a single cell and their common physicochemical properties, it has been very difficult to purify one of them free of contamination by others. As a result, monospecific antibodies directed against a single species of Ga protein are scarce. In addition, Ga-subunits share considerable structural and sequence homologies, which means that they may share common epitopes. Therefore, synthetic peptides corresponding to sequences unique to each studied Ga-subunit have been used as antigens, in the hope that they would elicit highly specific anti bodies (7, 8, 10, (14) (15) (16) .
In this study we present data obtained with several rabbit antisera raised against a peptide corresponding to part of the C-termind sequence of Gsa (residues 367-381). Unexpectedly, when applied to brain sections, all of the purified anti-peptide antibodies stained the cytoskeleton of vimentin-containing cells. However, Western blot analysis of brain subfractions showed that they failed to reveal vimentin but recognized a cytoskeleton-associated protein of 65 m. The latter did not appear to be a G-protein by current criteria. Ultrastructural studies confirmed the staining of intermediate filaments (IF) in Bergmann fibers and also revealed a weak reaction at the level of the plasma membrane of some nerve and glial cells, compatible with the detection of Gsa-subunits.
Materials and Methods

Peptide Synthesis
The Gra sequence 367-381 is VDTENIRRVFNDCRD. A tyrosine residue was added at the C terminus. The synthesis of the peptide was performed on an Applied Biosystems peptide synthesizer (Model 430A) by the solidphase method developed by Barany and Merrifield (17) . Tertio-butyloxycarbonyl ( t k ) amino acids with benzyl (T)-, cyclohexyl (D,E)-. and tosyl (R)-based side-chain protecting groups were sequentially added on a PAM resin. Amino acid side chain protections and peptide-resin bonds were cleaved during anhydrous hydrogen fluoride treatment (1 hr, 0°C). except for acetamidomethyl-Cys, which was kept protected. Purification of the peptide was achieved by filtration through Sephadex G-15 in 0.1 N acetic acid, followed by reverse-phase medium-pressure liquid chromatography on C-18 (15-25 mm) in 0.1% trifluoroacetic acid. Peptide homogeneity was checked by analytical high-pressure liquid chromatography and by amino acid analysis (6 N HCI, 1lO'C. 20 hr) . The uncorrected amino acid content was: D / N 4.97, T 0.93, E 1.03, V 1.94, 10.94, Y 0.84, F 1.00, R 3.11. [C (acm) is not detectable by this method.]
Preparation of Antibodies Tissues and Cells Mice (Mus ~U J C U~U J )
and Wistar rats were anesthetized and perfused with freshly prepared 4% paraformaldehyde in 0.1 M PB, pH 7.4, at room temperature. The cerebellum and brain were removed. The tissues were kept overnight at 4°C in the same solution. Lenses were obtained from monkeys, rats, and 4-week-old mice; the adhering epithelial cells were allowed to spread on slides and were fixed in acetone (4"C, 10 min). C2-7 mouse myoblasts (a gift of P. Vicart, Institut Pasteur, Paris) were grown in 15% fetal calf serum (FCS). When FCS was replaced by 2% horse serum, myoblasts differentiated into myotubes. Cultures of human fibroblasts were from Laboratoire dAnatomo-Pathologie, Hopital Sainte-Anne, Paris (a gift of R. Maunoury).
Immunocytochemical Methods
Both fluorescence and peroxidase labeling techniques were applied to fixed tissue sections or spread cells. The preparations were rinsed in PBS, incubated in 20% normal sheep or goat serum (10-30 min) , and incubated with the primary antibody overnight at 4°C. After washing, the primary antibody was revealed by anti-immunoglobulins conjugated to rhodamine, fluorescein, or peroxidase. The primary antibodies were: in the case of anti-G,, peptide sera, affinity-purified anti-peptide antibodies, 15 pg/ml (eluted from a resin coupled to the peptide; see below) (rabbits I and 11). or the diluted serum (rabbit 111). or protein A purified antibodies (100 pglml), or the corresponding controls (diluted pre-immune sera, antibodies, or material obtained by affinity chromatography of the pre-immune sera); a rabbit anti-vimentin serum (the generous gift of A.M. Hill, Orsay, France), diluted 1:400; diverse anti-GFAP sera [guinea pig, diluted 1:lOO (Biochimie des Antigenes; Institut Pasteur, Paris, France); rabbit, diluted 1:200 (Dako; Glostrup, Denmark) or monoclonal antibodies, diluted 1:lOO (Amersham; Poole, UK).
Fluorescence Immunocytochemistry. Sections (30 pm) of cerebella infiltrated with 40% sucrose were obtained with a Lancer vibratome. Sections were treated as indicated and the primary antibody was revealed by rhodamine-coupled goat anti-rabbit antibodies, diluted 1:ZOO Uackson Immunoresearch; West Grove, PA), for 1-3 hr at room temperature, and the sections were washed again. They were mounted in mowiol. In the case of cells, fluorescein-labeled sheep anti-rabbit (and anti-mouse) immunoglobulins diluted 1:lOO (Biosys; Compiegne, France) were used. Preparations were examined with a Zeiss microscope. In double-immunostaining experiments, anti-GFAP mouse monoclonal antibodies were mixed with the rabbit anti-Deotide antibodies and revealed with fluorescein-coniueated
Uncoupled peptide (1 mglrabbit) was emulsified with F m " s complete adjuvant. Three rabbits were injected in the two popliteal lymph nodes (two thirds of the preparation) and intradermally in the back. Intradermal booster injections of the same quantity of peptide emulsified in Freund's incomplete adjuvant were then repeated at 1-month intervals. Blood was anti-mouse antibodies and rhodamine-conjugated anti-rabbit antibodies.
In blocking experiments using the rabbit anti-vimentin serum, the "blocking" antibody was incubated overnight at 4'C (in control experiments the blocking antibody was replaced by PBS); the challenging antibody was then added and incubated for 2 hr at room temperature. drawn 1 month after the first injection and then at 1or 2-week intervals. The titers of the antisera were determined by ELISA, as described (18). Sera from rabbits I and I1 gave titers of 10,000-20,OOO; serum from rabbit 111 had a much lower titer.
Antibodies were purified by affinity chromatography on protein A-Sepharose or on a resin to which the peptide was coupled (rabbits I and 11). Pure anti-peptide antibodies were prepared by incubating dialyzed sera overnight on the peptide-coupled resin at 4°C (Sepharose CL4B. 3 mg peptide bound/ ml gel) (Pharmacia; Piscataway, NJ) (18). The resin was washed, bound material was released by acid treatment (0.2 M glycine-HC1, pH 2.5). immediately neutralized, dialyzed against phosphate buffer (PB), concentrated. and stored frozen at -2O' C in small aliquots. Pre-immune sera were treated in the same way, and the released material was used as control (dv) (18).
Peroxidase Immunocytochemistry. Rats were perfused with 4% paraformaldehyde, 0.1% glutaraldehyde in PB. Sections of 30 pm were cut on a Lancer vibratome and treated as described (19), using peroxidase-conjugated sheep F(ab) anti-rabbit immunoglobulins diluted 1:lOO (Biosys). In some cases the sections were osmicated, dehydrated, and flat-embedded in araldite. Selected areas were cut and glued to araldite blocks. Ultra-thin sections were cut, counterstained with 2% lead nitrate, and viewed in a CM 10 Philips electron microscope.
Su bcellular Fractionation
Two-month-old, anesthetized rats were decapitated. The brains and cerebella were removed and homogenized in 10 volumes of ice-cold 50 mM Tris-HCI buffer, pH 7.5. containing 5 mM MgC12, 10% sucrose, 10 pglml inhibitors of proteases (leupeptin, chymosratin. aprorinin, trypsin inhibitor), 1 mM phenylmethanesulfony1 fluoride (Buffer A). The homogenate was centrifuged (100.000 x g. 1 hr, 4'C). The cytosol was saved, and the pellet was re-suspended in the same buffer, solubilized with Lubrol-PX (Lubro1:prorein ratio of 2.5. final concentration Of 0.9%) as described (18). The Lubrol-insoluble material was referred to as the cytoskeletal fraction. Synaptosomes were prepared as described (18). Proteins of all fractions (homogenate. cytosol, Lubrol-soluble proteins. cytoskeletal fraction. synaptosomes) were precipitated by addition of cold trichloroacetic acid (15% final concentration, 15 min) and measured by the Schaffner and Weissmann method (20).
Miscelluneous
In some cases the 100,000 x g pellet was incubated in the presence of DNAse I and 50 mM MgClz for 10 min at 30°C before Lubrol solubilization. Proteins were analyzed by SDS-PAGE and transferred onto nitrocellulose sheets (18). Immunoblotting procedures were as described (18). Subcellular fractions were ADFribosylared with cholera toxin and with pertussis toxin. as described (21.22). The treated proteins were blotted. Blots were analyzed by autoradiography, then subjected to immunodetecrion.
Vimentin-lihe Distribution of the Immunoreactive Muteriul in Fixed Sections and Cells
The staining patterns obtained with the two sets of purified antipeptide antibodies (rabbits I and 11) were identical; all controls were negative. A slight, unspecific staining was noted with the preimmune and the immune serum of rabbit 111.
In the rodent CNS. anti-peptide antibodies stained astroglial cells containing vimentin. Astroglia, as defined by morphology, location, and/or GFAP or vimentin content, were the only cell popu-",. lation stained in the CNS by the anti-peptide antibodies. This population was composed of the cerebellar Bergmann fibers (Figure la) , perivascular astrocytes in the cerebellum (Figure la ) and brain, subpial astrocytes, fibrous astrocytes (Raff T~K 11) in brain and cerebellar white matter (Figure 2a ), and ependymal cells (Figure 2c . spinal cord). In the fetal rat CNS. anti-peptide antibodies stained radial fibers spanning the entire width of the brain cortex (embryonic radial glia) (Figure 3) . These processes later disappeared as the adult pattern of vimentin and GFAP appeared. Eble 1 s h w that the anti-peptide antibodies stained many but not all GFAPpositive cell types (see also Figures 2c and 2d) , whereas they stained all vimentin-positive cells. Double immunostaining with both antivimentin and anti-peptide antibodies showed co-localization of the antigens in the same cells (not shown). Pre-incubation of mouse brain sections with unlabeled anti-vimentin serum partially blocked the immunofluorescence caused by the anti-peptide antibodies, and vice versa.
Vimentin-containing cells of non-neuroectodermal origin were stained by the anti-peptide antibodies. Mouse, rat. and monkey lens epithelial cells (of ectodermal origin) were stained by antipeptide ( Figure 4 ) and anti-vimentin antibodies (Eble I), and so were human fibroblasts ( Figure 4b ). Myoblasts (of mesodermal origin) were recognized by anti-vimentin and anti-peptide antibodies, whereas differentiated myotubes lost both immunoreactivities (not shown).
The anti-peptide antibodies clearly stained the cytoskeleton of various cell types. This was particularly well seen in largely spread cells such as lens epithelial cells (Figure 4a ) and cultured human fibroblasts ( Figure Sb) . EM cytochemistry studies of rat cerebellar sections confirmed the cytoskeletal immunoreactivity of Bergmann fibers ( Figure Sa) , loaded with peroxidase deposits all along what appeared to be intermediate filaments ( Figure Sb) .
The anti-peptide antibodies stained some areas of nerve and glial membranes. EM cytochemistry revealed the immunoreactivity of the inner surface of plasma membranes in Bergmann fibers (Figure 5b , arrows) and in some, but not all, nerve endings ( Figure  5b, circles) . The reaction products were discontinuous along the plasma membrane of a given cell and were present in some cerebellar areas but not in others. In areas containing labeled cytoskele- ton, mitochondrial intermembrane spaces and membranes were occasionally stained: diffusion of the reaction products may have occurred (Figure 5b) . The latter hypothesis warrants further studies conducted with gold-labeled secondary antibodies.
Western Blot Staining of Rat Brain Proteins by Anti-peptide Antiboa'zes
Western blots of several independent preparations of rat brain fractions (cytosol, 100,000 x g pellet, and the corresponding Lubrolsoluble and -insoluble fractions, synaptosomes) were reacted with the anti-peptide sera or antibodies (purified on peptide-coupled resin or on protein A-Sepharose). One component, a protein of 65 KD. was detected in the 100,000 x g pellet and in the Lubrolinsoluble fraction by all sets of sera or antibodies ( Figure 6 , Lanes 3-5). In Western blots containing material prepared from DNAse I-treated 100,000 x g pellets, the 65 KD protein revealed by the antibodies was found in the Lubrol-soluble fraction (most probably as a result of proteolysis during the incubation of samples with the commercial DNAse I used here).
The anti-peptide antibodies failed to detect proteins in the molecular weight range of in any of the blotted fractions. We therefore verified that the G-proteins present in the subcellular fractions were correctly transferred onto our blots by subjecting the fractions to cholera toxin and pertussis toxindirected ADP ribosylations (21, 22) . ADP-ribosylated G,a-subunits (46 and 52 KD) were visualized in autoradiographs of blots of Lubrolsoluble material (Figure 7 , Lane c) but not of cytoskeletal fractions. In the latter, pertussis toxin ADP ribosylated material of low molecular weight range only (20-30 KD) (not shown). After autoradiography, the blots were treated by the anti-peptide antibodies. The ADP-ribosylated proteins were not revealed by the antibodies, whereas the non-radioactive, 65 KD protein was recognized.
Since immunocytochemical studies had indicated that antipeptide antibodies stained what appeared to be vimentin, two additional tests were performed. First, blots of the various samples were probed with antibodies raised against vimentin. In our blots of Lubrol-insoluble material (calibrated with commercial MW mark- Reaction product was deposited in the vicinity of the cytoskeleton (arrows) and along the cytoplasmic face of some areas of plasma membranes (nerve and glial cells) and scattered nerve endings (circles). Precipitates were also seen in the mitochondrial intermembrane space. Bars: a = 1 pm; b = 0.5 pm. Immunocbemicaf staining of va~ous cell types, obtained witb anti-Gm peptide, anri-vimentin, and (Figure 6. Lane 1) and was clearly distinct from the 65 KD protein stained by the antipeptide antibodies on the same blots (Figure 6 . . Second. anti-peptide antibodies were pre-incubated with a large excess of commercial vimentin. The immunoreactivity of the 65 KD protein was not diminished by this procedure. The 65 KD protein was also distinct from the proteins stained on the same blots by anti-tau, anti-neurofilament, and anti-tubulin antibodies (Sigma; St Louis, MO) (not shown). teins from an aliquot incubated in the absence of cholera toxin (Lane b) and from an aliquot incubated in its presence (Lane c) were contiguous in this blot. Radiolabeled G-,-subunits of 46 and 52 KD were detected in Lane C but n d in Lane b. These proteins were not recognized by the anti-peptide antibodies. nor was the unspecifically labeled protein of 130 KD detected.
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Discussion
In this study, we tried to immunolocalize the adenylyl cyclase stimulatory GSa-subunits in mammalian CNS sections and in various cultured cells. We used antibodies raised against a hydrophilic peptide whose sequence is unique to Gsa and which is thought to be exposed on the surface of the protein. Unexpectedly, neither the biochemical study (Western blot analysis of subcellular brain fractions) nor the immunohistochemical localization at the optical level seemed to be consistent with the detection of Gsa-subunits or of G-proteins. First, the protein visualized in immunoblots had an apparent molecular weight of 65 KD instead of 42-52 KD, the usual range for G-proteins. Second, cholera and pertussis toxins were able to ADP-ribosylate several proteins in our subcellular fractions, but not this 65 KD protein.
[It is, however, to be recalled that high molecular weight proteins that failed so far to be ADPribosylated have tentatively been assigned to the G-protein family) (23).] Third, subcellular fractionation showed that the 65 KD protein was principally found in the Lubrol-insoluble fraction, where most of the cytoskeletal proteins are usually found. Finally, the immunocytochemical study of cultured cells at the optical level, or of cerebellar sections at the EM level, showed that affinity-purified anti-peptide antibodies recognized structures usually considered as a vimentin-based cytoskeleton. Moreover, in cultures of myocytes, when vimentin ceases to be synthesized at the time when they differentiate into myotubes, the anti-peptide immunoreactivity disappeared. The immunostained protein, however, appeared not to be vimentin in Western blots, but a distinctively higher molecular weight component.
In addition to this cytoskeletal localization, ultrastructural immunocytochemistry enabled us to reveal scattered areas of the plasma membrane of nerve endings and glial cells that were clearly recognized by the anti-peptide antibodies. The reaction at this level was relatively faint, indicating that the amount of antigen in the plasma membrane was probably too weak to allow detection at the optical level. At the ultrastructural level, the immunocytochemical staining of the plasma membranes may well correspond to authentic Gsa-subunits, given the very low abundance of these proteins (9) . However, the anti-Gsa antibodies responsible for the cytochemical reaction did not recognize the blotted protein, either because of the type of denaturation undergone by the protein during the immunoblotting procedure or because of a difference in the sensitivity of signal detection between immunocytochemistry and immunoblotting.
From these results, it appears that the Gsa peptide used here as antigen elicited, in several animals, two distinctly different types of antibody populations concomitantly: one recognizing epitopes present on Gsa-subunits in fixed tissues, the other recognizing an epitope located in a cytoskeletal, vimentin-associated protein.
The present study illustrates the difficulties encountered when anti-peptide antibodies are used to immunolocalize the protein in which the peptide sequence is present. Such an approach is often attempted, especially in the case of cDNA sequences coding for proteins of unknown function. Antibodies raised against a peptide corresponding to such a DNA stretch are expected to allow the identification and/or localization of the "parent" protein. However, as illustrated by our study, a very careful assessment of the results is needed. It is well known indeed that a peptide sequence as short as three or four residues is capable of eliciting antibodies, and it is obvious that such a short sequence is likely to occur in several distinct proteins (24). Likewise, anti-peptide antibodies may recognize conformational (rather than linear) epitopes, and the latter can be present in proteins that do not contain the linear sequence of the peptide (24). As a result, proteins irrelevant to the study may well be identified. Finally, another often unappreciated difficulty pertains to the fact that an antibody that recognizes a given protein in Western blots or in ELISA tests does not necessarily recognize this protein in fixed tissue sections or cells, or vice versa. Indeed, aldehyde fixation modifies some of the protein side chains and hence their immunoreactivity (25) . Polyclonal antibodies raised against a protein are directed against a number of determinants, not all of which are modified by fixation. When used in immunolocalization studies, they are unlikely to lead to spurious recognitions. The risk of false localizations is higher with anti-peptide antibodies, since the latter recognize an extremely limited domain of a protein, often a single epitope, which may be modified by fixatives. Ideally, a comparison of data obtained with a set of antipeptide antibodies directed against distinct peptides from a given protein sequence should be done, and should eventually allow an unambiguous localization of the protein.
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